Stanford University
Showing 511-520 of 529 Results
-
Bryan Wu, MD
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Wu is a board-certified cardiologist at Stanford Health Care. He is also a clinical assistant professor in the Division of Cardiovascular Medicine. His areas of clinical focus include general and preventive cardiology with a particular interest in cardiac imaging. Dr. Wu has board certification in echocardiography, cardiovascular CT, and cardiac nuclear imaging.
Dr. Wu speaks fluent Chinese and Spanish and embraces racial, ethnic, and socioeconomic diversity in his clinical care. He has international clinical/research experiences in Italy and Mexico, and truly enjoys meeting and working with people from distinctive backgrounds.
Dr. Wu is passionate about clinical research. He has pursued scholarly work on the utilization of therapeutic drug monitoring for antihypertensive therapy and statins to help patients from low socioeconomic backgrounds improve their medication adherence. He is also involved in research on advanced cardiac imaging and has actively investigated the applications of cardiac CT in electrophysiology interventions.
Dr. Wu’s research has been published in peer-reviewed journals such as the International Journal of Cardiology and Journal of Vascular Surgery. He has presented his work at regional and national meetings, including the American Heart Association’s annual Scientific Sessions.
Dr. Wu is a member of the American College of Physicians, American Heart Association, and American Medical Association. -
Joseph C. Wu, MD, PhD
Director, Stanford Cardiovascular Institute, Simon H. Stertzer, MD, Professor and Professor of Radiology
Current Research and Scholarly InterestsDrug discovery, drug screening, and disease modeling using iPSC.
-
Sean M. Wu
Professor of Medicine (Cardiovascular Medicine) and, by courtesy, of Pediatrics
Current Research and Scholarly InterestsMy lab seeks to identify mechanisms regulating cardiac lineage commitment during embryonic development and the biology of cardiac progenitor cells in development and disease. We believe that by understanding the transcriptional and epigenetic basis of cardiomyocyte growth and differentiation, we can identify the most effective ways to repair diseased adult hearts. We employ mouse and human embryonic and induced pluripotent stem cells as well as rodents as our in vivo models for investigation.
-
Joanna Wysocka
Lorry Lokey Professor and Professor of Developmental Biology
Current Research and Scholarly InterestsThe precise and robust regulation of gene expression is a cornerstone for complex biological life. Research in our laboratory is focused on understanding how regulatory information encoded by the genome is integrated with the transcriptional machinery and chromatin context to allow for emergence of form and function during human embryogenesis and evolution, and how perturbations in this process lead to disease.
-
Fan Yang
Associate Professor of Orthopaedic Surgery and of Bioengineering
On Leave from 03/01/2026 To 03/31/2026Current Research and Scholarly InterestsOur lab’s mission is to develop therapies for regenerating human tissues lost due to diseases or aging, and to build tissue engineered 3D models for understanding disease progression and informing drug discovery. We invent biomaterials and engineering tools to elucidate and modulate biology, and also use biology to inform materials and engineering design. Our work is highly interdisciplinary, and is driven by unmet clinical needs or key gaps in biology.
-
Phillip C. Yang, MD
Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsDr. Yang is a physician-scientist whose research interest focuses on clinical translation of the fundamental molecular and cellular processes of myocardial restoration. His research employs novel in vivo multi-modality molecular and cellular imaging technology to translate the basic innovation in cardiovascular pluripotent stem cell biologics. Dr. Yang is currently a PI on the NIH/NHLBI funded CCTRN UM1 grant, which is designed to conduct multi-center clinical trial on novel biological therapy.
-
Yunzhi Peter Yang
Professor of Orthopaedic Surgery and, by courtesy, of Materials Science and Engineering and of Bioengineering
On Partial Leave from 12/01/2025 To 05/31/2026Current Research and Scholarly InterestsThe Yang Lab focuses on next-generation solutions at the intersection of 3D printing, regenerative medicine, modular tissue engineering, biomaterials, and medical device innovation. Our research focuses on engineering dynamic, biomimetic microenvironments that promote cell growth, tissue regeneration, and functional restoration. We develop transformative technologies to treat a broad spectrum of musculoskeletal conditions—including multi-tissue healing challenges and complex traumatic injuries.
-
Alan Yeung, MD
Li Ka Shing Professor in Cardiology
Current Research and Scholarly InterestsCoronary artery disease is the leading cause of death in men and women in the United States. Our group is interested in studying both the early and late phases of atherosclerosis so that we can better develop prevention and treatment strategies.
-
Paul Yock, MD
Martha Meier Weiland Professor in the School of Medicine and Professor of Bioengineering, Emeritus
Current Research and Scholarly InterestsHealth technology innovation using the Biodesign process: a systematic approach to the design of biomedical technologies based on detailed clinical and economic needs characterization. New approaches for interdisciplinary training of health technology innovators, including processes for identifying value opportunities in creating new technology-based approaches to health care.
